• <em>WAS</em>-Related Disorders
• An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid
• An infant with chronic severe neutropenia
• Antibiotics Associated With Clostridium difficile Infection
• Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population
• Autologous CD19- targeting CAR T cells in refractory juvenile dermatomyositis
• Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
• AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001
• Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
• Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
• Case Report of 11 Years of Severe Malabsorption, Muscular Atrophy, Seizures, and Immunodeficiency Resolved After Proximal Intercessory Prayer
• Chronic neutropenia in adults
• Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis
• Congenital neutropenia: From lab bench to clinic bedside and back
• Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review
• ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry
• Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study
• Evans Syndrome
• EXPRESS: Predictive Modeling of Mortality in Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections Using Machine Learning
• HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR)
• Immediate Hypersensitivity Reactions
• Inborn errors of immunity with susceptibility to <em>S. aureus</em> infections
• Increased frequency of the single nucleotide polymorphism of the DARC/ACKR1 gene associated with ethnic neutropenia in a cohort of European patients with chronic idiopathic neutropenia
• Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital
• Iron overload induced by diphenylamine triggers reactive oxygen species and apoptosis in the spleen of pregnant rats and their fetuses
• Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment
• Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis
• Mesenchymal stem cells in immune-mediated bone marrow failure syndromes
• Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity
• Neutropenia
• Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor
• Oral health management in children with severe congenital neutropenia with periodontitis: Case report
• Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry
• Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
• Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review
• Platelet count and dose, but not comorbidities, predict severe neutropenia in cabazitaxel-treated prostate cancer patients: A retrospective observational study
• Predictive modeling of mortality in carbapenem-resistant <em>Acinetobacter baumannii</em> bloodstream infections using machine learning
• PREDICTIVE VALUE OF SOLUBLE PROGRAMMED CELL DEATH LIGAND-1 IN THE PROGRESSION OF SEPTIC PATIENTS TO CHRONIC CRITICAL ILLNESS IN THE INTENSIVE CARE UNIT: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY
• Presumed pseudo-Pelger-Huet anomaly and basophilia secondary to chronic lymphocytic leukemia in a dog
• Quality of life and patient-reported outcomes in chronic severe neutropenia conditions
• Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE-related neutropenia: a French Severe Chronic Neutropenia Registry study
• Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry
• Rhinocerebral Mucormycosis
• Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study
• Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
• Severe chronic primary neutropenia in adults: report on a series of 108 patients
• Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment
• Shwachman-Diamond syndrome and solid tumors: Three new patients from the French Registry for Severe Chronic Neutropenia and literature review
• Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule
• The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
• The paradox of autoimmunity and autoinflammation in inherited neutrophil disorders - in search of common patterns
• The promise of novel treatments for severe chronic neutropenia
• The Therapeutic Potential of Angeli's Salt in Mitigating Acute <em>Trypanosoma cruzi</em> Infection in Mice
• Tolerability of Daratumumab Amongst Asian Patients with Plasma Cell Dyscrasias - A Single Centre Experience
• Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia